The global diabetic neuropathy market, valued at USD 4.90 billion in 2024, is expected to grow at a CAGR of 6.99% during 2025–2034, reaching USD 9.63 billion by 2034, driven by the rising prevalence of diabetes, growing complications, and increasing demand for effective treatment options. https://www.expertmarketresearch.com/reports/diabetic-neuropathy-market